Logo

UBS

UBS Initiates Coverage of Bruker With Buy Rating

The bank said factors including Bruker's increasing exposure to consumables and pharma end markets as well as increased US federal funding would drive growth.

Singular Genomics Ups IPO Target to $187M

The San Diego-based DNA sequencing startup plans to offer 8.5 million shares at an IPO price between $20 and $22 per share, for a $1.5 billion valuation.

Sequencing Startup Singular Genomics Files for $100M IPO

The San Diego-based company, led by a raft of Illumina veterans, is planning to build a new sequencing platform to address genomic and multiomic analysis.

NanoString Technologies Prices $200M Public Offering

The Seattle-based genomics technology firm said it intends to use the funds for working capital and general corporate purposes.

NanoString Technologies Q3 Preliminary Product, Service Revenues Grow 14 Percent

The company expects product and service revenue totaling $30.1 million, driven by higher instrument revenue, offset by declining consumables revenue.